{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:05:03Z","timestamp":1763017503074,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T00:00:00Z","timestamp":1422230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/bmt.2014.306","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T19:00:30Z","timestamp":1422298830000},"page":"592-597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP"],"prefix":"10.1038","volume":"50","author":[{"given":"A","family":"Lawitschka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Veys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wachowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Socie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"Aljurf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Arat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-8515","authenticated-orcid":false,"given":"C","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,26]]},"reference":[{"key":"BFbmt2014306_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/sj.bmt.1705923","volume":"41","author":"P Satwani","year":"2008","unstructured":"Satwani P, Cooper N, Rao K, Veys P, Amrolia P . Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008; 41: 173\u2013182.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bmt.1704399","volume":"33","author":"G Del Toro","year":"2004","unstructured":"Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid Bradley M, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613\u2013622.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1083-8791(03)70004-4","volume":"9","author":"D Gomez-Almaguer","year":"2003","unstructured":"Gomez-Almaguer D, Ruiz-Arguelles GJ, Tarin-Arzaga Ldel C, Gonzalez-Llano O, Jaime-Perez JC, Lopez-Martinez B et al. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. Biol Blood Marrow Transplant 2003; 9: 157\u2013161.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014306_CR4","first-page":"2314","volume":"104","author":"R Duerst","year":"2004","unstructured":"Duerst R, Jacobsohn D, Tse WT, Kletzel M . Efficacy of reduced intensity conditioning (RIC) with FLU-BU-ATG and allogeneic hematopoietic stem cell transplantation (HSCT) for pediatric ALL. ASH Annual Meeting Abstracts 2004; 104: 2314.","journal-title":"ASH Annual Meeting Abstracts"},{"key":"BFbmt2014306_CR5","doi-asserted-by":"publisher","first-page":"7164\u2009s","DOI":"10.1158\/1078-0432.CCR-1004-0018","volume":"11","author":"E Roman","year":"2005","unstructured":"Roman E, Cooney E, Harrison L, Militano O, Wolownik K, Hawks R et al. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. Clin Cancer Res 2005; 11: 7164\u2009s\u20137170\u2009s.","journal-title":"Clin Cancer Res"},{"key":"BFbmt2014306_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00277-003-0814-y","volume":"83","author":"A Claviez","year":"2004","unstructured":"Claviez A, Klingebiel T, Beyer J, Nurnberger W, Ehninger G, Suttorp M et al. Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease. Ann Hematol 2004; 83: 237\u2013241.","journal-title":"Ann Hematol"},{"key":"BFbmt2014306_CR7","first-page":"195","volume":"114","author":"A Nagler","year":"2009","unstructured":"Nagler A, Labopin M, Shimoni A, Volin L, Bunjes DW, Huynh A et al. Comparison of outcomes after allogeneic HSCT for adult patients with AML in remission using in the conditioning regimen either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey. ASH Annual Meeting Abstracts 2009; 114: 195.","journal-title":"ASH Annual Meeting Abstracts"},{"key":"BFbmt2014306_CR8","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1182\/blood-2009-01-196303","volume":"114","author":"MA Pulsipher","year":"2009","unstructured":"Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009; 114: 1429\u20131436.","journal-title":"Blood"},{"key":"BFbmt2014306_CR9","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.bmt.1704846","volume":"35","author":"P Veys","year":"2005","unstructured":"Veys P, Rao K, Amrolia P . Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning. Bone Marrow Tansplant 2005; 35: S45\u2013S47.","journal-title":"Bone Marrow Tansplant"},{"key":"BFbmt2014306_CR10","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/bmt.2008.48","volume":"41","author":"I Yaniv","year":"2008","unstructured":"Yaniv I, Stein J, Party EPW . Reduced-intensity conditioning in children: a reappraisal in 2008. Bone Marrow Transplant 2008; 41: S18\u2013S22.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.bmt.1705730","volume":"40","author":"B Strahm","year":"2007","unstructured":"Strahm B, Locatelli F, Bader P, Ehlert K, Kremens B, Zintl F et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007; 40: 329\u2013333.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR12","first-page":"621","volume":"13","author":"R Champlin","year":"1999","unstructured":"Champlin R, Khouri I, Komblau S, Molidrem J, Giralt S . Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology 1999; 13: 621\u2013628 discussion 631, 635\u2013638, 641.","journal-title":"Oncology"},{"key":"BFbmt2014306_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bmt.1702385","volume":"25","author":"A Bacigalupo","year":"2000","unstructured":"Bacigalupo A . Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2000; 25: 803\u2013805.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bmt.1703355","volume":"29","author":"A Bacigalupo","year":"2002","unstructured":"Bacigalupo A . Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 2002; 29: 191\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/sj.bmt.1704416","volume":"33","author":"A Bacigalupo","year":"2004","unstructured":"Bacigalupo A . Third EBMT\/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691\u2013696.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628\u20131633.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014306_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367\u2013369.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014306_CR18","volume-title":"The EBMT Handbook Haemopoietic Stem Cell Transplantation","author":"JCE Apperley","year":"2012","unstructured":"Apperley J CE, Gluckman E, Masszi T . Principles of conditioning. The EBMT Handbook Haemopoietic Stem Cell Transplantation, 6th edn. European School of Haematology, 2012."},{"key":"BFbmt2014306_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1703819","volume":"30","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A . European Group for Blood and Marrow Transplantation (EBMT). Accreditation Committee.. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant 2002; 30: 813\u2013831.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR20","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1038\/sj.bmt.1704845","volume":"35","author":"J Stein","year":"2005","unstructured":"Stein J, Dini G, Yaniv I . Pediatric Diseases Working Party of the EBMT. The hope and the reality of reduced intensity transplants in children with malignant diseases. Bone Marrow Transplant 2005; 35: S39\u2013S43.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR21","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1600-0609.2012.01776.x","volume":"88","author":"M Strullu","year":"2012","unstructured":"Strullu M, Rialland F, Cahu X, Brissot E, Corradini N, Thomas C et al. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience. Eur J Haematol 2012; 88: 504\u2013509.","journal-title":"Eur J Haematol"},{"key":"BFbmt2014306_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/bmt.2011.69","volume":"47","author":"SM Luger","year":"2012","unstructured":"Luger SM, Ringden O, Zhang MJ, Perez WS, Bishop MR, Bornhauser M et al. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant 2012; 47: 203\u2013211.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood-2004-03-0960","volume":"105","author":"K Rao","year":"2005","unstructured":"Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879\u2013885.","journal-title":"Blood"},{"key":"BFbmt2014306_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.bmt.1705778","volume":"40","author":"LM Burroughs","year":"2007","unstructured":"Burroughs LM, Storb R, Leisenring WM, Pulsipher MA, Loken MR, Torgerson TR et al. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Bone Marrow Transplant 2007; 40: 633\u2013642.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2014306_CR25","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","volume":"117","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S et al. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood 2011; 117: 4367\u20134375.","journal-title":"Blood"},{"key":"BFbmt2014306_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.bbmt.2013.11.027","volume":"20","author":"IH Bartelink","year":"2014","unstructured":"Bartelink IH, van Reij EM, Gerhardt CE, van Maarseveen EM, de Wildt A, Versluys B et al. Fludarabine and exposure-targeted busulfan compares favorably with busulfan\/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity. Biol Blood Marrow Transplant 2014; 20: 345\u2013353.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014306_CR27","first-page":"143","volume":"6","author":"M Andreani","year":"2008","unstructured":"Andreani M, Testi M, Battarra M, Indigeno P, Guagnano A, Polchi P et al. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia. Blood Transfus 2008; 6: 143\u2013149.","journal-title":"Blood Transfus"},{"key":"BFbmt2014306_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T Gungor","year":"2014","unstructured":"Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014; 383: 436\u2013448.","journal-title":"Lancet"},{"issue":"1","key":"BFbmt2014306_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/asheducation-2005.1.384","volume":"2005","author":"S. Giralt","year":"2005","unstructured":"Giralt S . Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years? Hematology Am Soc Hematol Educ Prog 2005, 384\u2013389.","journal-title":"Hematology"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014306","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:07:23Z","timestamp":1648058843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,26]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFbmt2014306"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.306","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2015,1,26]]},"assertion":[{"value":"15 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}